Publication | Closed Access

Incidence and in-vivo relevance of anti-interferon antibodies during treatment of low-grade cutaneous T-cell lymphomas with interferon alpha-2a combined with acitretin or PUVA

Lymphoid NeoplasiaAutoimmune DiseaseIn-vivo RelevanceMedicineAnti-interferon AntibodiesImmunologyAutoimmunityDermatologyDermatopathologyImmunotherapyInterferon Alpha-2aAdult T-cell Leukemia-lymphoma